Claire Advokat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Claire Advokat has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Benjamin David Hill
Department of Psychology, University of South Alabama, Mobile, AL, USA
2 shared publications Devan Guidry
LSU Med Sch, Hlth Sci Ctr, New Orleans, LA USA
2 shared publicationsJoseph E. Comaty
Louisiana State University
2 shared publicationsLeslie Martino
2 shared publicationsBa
1 shared publicationChunqiao Luo
Louisiana State University, Baton Rouge, LA
1 shared publication
Latest Publications
- 1 January 2013
- Published by Springer Nature
- p. 2497-2502
Opioids and Reflexes
- Open Access
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 7, 82
Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers
Recent increases in ADHD diagnoses, and the escalation of stimulant prescriptions, have raised concern about diversion and abuse of stimulants, as well as the ethics of using these drugs as ‘cognitive enhancers.’ Such concern appears misplaced in the face of substantial evidence that stimulant drugs do not improve the academic performance of ADHD-diagnosed students. Moreover, numerous studies have found little or no benefit of stimulants on neuropsychological tests of ADHD-diagnosed as well as normal, individuals. This paper examines the apparent paradox: why don’t drugs that improve ‘attention,’ produce better academic outcomes in ADHD-diagnosed students? We found that stimulant drugs significantly improved impairment of episodic memory in ADHD-diagnosed undergraduate students. Nevertheless, we also found consistent academic deficits between ADHD students and their nonADHD counterparts, regardless of whether or not they used stimulant medications. We reviewed the current literature on the behavioral effects of stimulants, to try to find an explanation for these conflicting phenomena. Across a variety of behavioral tasks, stimulants have been shown to reduce emotional reactions to frustration, improve the ability to detect errors, and increase effortful behavior. However, all of these effects would presumably enhance academic performance. On the other hand, the drugs were also found to promote ‘risky behavior’ and to increase susceptibility to environmental distraction. Such negative effects, including the use of drugs to promote wakefulness for last minute study, might explain the lack of academic benefit in the ‘real world,’ despite their cognitive potential. Like many drugs, stimulants influence behavior in multiple ways, depending on the environmental contingencies. Depending on the circumstances, stimulants may, or may not, enhance cognition.
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 7, 82
Open AccessAttention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers
Recent increases in ADHD diagnoses, and the escalation of stimulant prescriptions, have raised concern about diversion and abuse of stimulants, as well as the ethics of using these drugs as ‘cognitive enhancers.’ Such concern appears misplaced in the face of substantial evidence that stimulant drugs do not improve the academic performance of ADHD-diagnosed students. Moreover, numerous studies have found little or no benefit of stimulants on neuropsychological tests of ADHD-diagnosed as well as normal, individuals. This paper examines the apparent paradox: why don’t drugs that improve ‘attention,’ produce better academic outcomes in ADHD-diagnosed students? We found that stimulant drugs significantly improved impairment of episodic memory in ADHD-diagnosed undergraduate students. Nevertheless, we also found consistent academic deficits between ADHD students and their nonADHD counterparts, regardless of whether or not they used stimulant medications. We reviewed the current literature on the behavioral effects of stimulants, to try to find an explanation for these conflicting phenomena. Across a variety of behavioral tasks, stimulants have been shown to reduce emotional reactions to frustration, improve the ability to detect errors, and increase effortful behavior. However, all of these effects would presumably enhance academic performance. On the other hand, the drugs were also found to promote ‘risky behavior’ and to increase susceptibility to environmental distraction. Such negative effects, including the use of drugs to promote wakefulness for last minute study, might explain the lack of academic benefit in the ‘real world,’ despite their cognitive potential. Like many drugs, stimulants influence behavior in multiple ways, depending on the environmental contingencies. Depending on the circumstances, stimulants may, or may not, enhance cognition.
- 1 January 2012
- Vol. 40 (1) , 89-97
Competency Restoration Treatment: Differences Between Defendants Declared Competent or Incompetent to Stand Trial
Archival data of inpatient defendants referred for competency restoration were used to make comparisons between those who were restored to competency (CST; n = 43) and those who remained incompetent (IST; n = 15). The groups did not differ on demographic variables, intellectual capacity, type of offense (violent versus nonviolent), clinical diagnoses, substance abuse, or psychotic symptomatology, as measured by the Brief Psychiatric Rating Scale. However, the CST group performed significantly better than the IST group on both the initial and final Georgia Court Competency Test and Global Assessment of Functioning scale. Psychotic symptom severity decreased significantly only in the CST group, and the CST group was discharged significantly sooner (7.7 +/- 8.6 months) than the IST group (17.9 +/- 7.0 months). While consistent with prior research, this is the first study to compare both psycholegal comprehension and specific clinical symptoms in defendants before and after competency restoration treatment.
- 1 January 2012
- Vol. 40 (1) , 89-97
Competency Restoration Treatment: Differences Between Defendants Declared Competent or Incompetent to Stand Trial
Archival data of inpatient defendants referred for competency restoration were used to make comparisons between those who were restored to competency (CST; n = 43) and those who remained incompetent (IST; n = 15). The groups did not differ on demographic variables, intellectual capacity, type of offense (violent versus nonviolent), clinical diagnoses, substance abuse, or psychotic symptomatology, as measured by the Brief Psychiatric Rating Scale. However, the CST group performed significantly better than the IST group on both the initial and final Georgia Court Competency Test and Global Assessment of Functioning scale. Psychotic symptom severity decreased significantly only in the CST group, and the CST group was discharged significantly sooner (7.7 +/- 8.6 months) than the IST group (17.9 +/- 7.0 months). While consistent with prior research, this is the first study to compare both psycholegal comprehension and specific clinical symptoms in defendants before and after competency restoration treatment.
- 2 August 2010
- Published by SAGE Publications in Journal of Attention Disorders
- Vol. 15 (8) , 656-666
College Students With and Without ADHD
Objective: To examine the relationship between ADHD medications, study habits, and academic achievement of ADHD-diagnosed undergraduates. Method: A total of 92 students with a self-reported ADHD diagnosis and a current prescription for ADHD medication were compared with 143 control students in a survey of academic performance. Results: Most ADHD students took stimulant medication and said the drugs helped them, yet believed they were worse than other students at planning and completing assignments and avoiding distractions. Although most study habits of ADHD students did not differ from controls, their high school and college GPA (grade point average), and ACT scores were significantly lower, and they withdrew from significantly more classes than did control students. Interestingly, preliminary data suggested that good study habits alone, even without stimulants, could overcome the achievement disparity of ADHD students. Conclusion: As previously shown for children and adolescents, stimulant medications alone did not eliminate the academic achievement deficit of ADHD undergraduates.
- 2 August 2010
- Published by SAGE Publications in Journal of Attention Disorders
- Vol. 15 (8) , 656-666
College Students With and Without ADHD
Objective: To examine the relationship between ADHD medications, study habits, and academic achievement of ADHD-diagnosed undergraduates. Method: A total of 92 students with a self-reported ADHD diagnosis and a current prescription for ADHD medication were compared with 143 control students in a survey of academic performance. Results: Most ADHD students took stimulant medication and said the drugs helped them, yet believed they were worse than other students at planning and completing assignments and avoiding distractions. Although most study habits of ADHD students did not differ from controls, their high school and college GPA (grade point average), and ACT scores were significantly lower, and they withdrew from significantly more classes than did control students. Interestingly, preliminary data suggested that good study habits alone, even without stimulants, could overcome the achievement disparity of ADHD students. Conclusion: As previously shown for children and adolescents, stimulant medications alone did not eliminate the academic achievement deficit of ADHD undergraduates.
- 1 July 2010
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 34 (8) , 1256-1266
What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD)
- 1 July 2010
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 34 (8) , 1256-1266
What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD)
- 1 May 2008
- Published by Taylor & Francis in Journal of American College Health
- Vol. 56 (6) , 601-6
Licit and Illicit Use of Medications for Attention-Deficit Hyperactivity Disorder in Undergraduate College Students
Objective: The authors studied the relationship between a diagnosis of Attention-Deficit Hyperactivity Disorder (ADHD), grade point average (GPA), and licit and illicit drug use. Participants and Methods: They obtained survey data from a convenience sample of undergraduates in a large southern public university. Results: Among 1,550 respondents, 163 (10.5%) reported an ADHD diagnosis (ADHD Group). Of those without an ADHD diagnosis, 591 (43%) reported using prescription stimulants illicitly (No ADHD, Illicit Use group), and 794 (57%) reported not using prescription drugs illicitly (No ADHD, No Illicit Use group). The GPA of the ADHD group was significantly lower than the GPA of the other 2 groups. The ADHD group and the No ADHD, Illicit Use group reported significantly greater use of all other drugs than did the No ADHD, No Illicit Use group. Conclusions: Drug use was associated with a lower GPA in ADHD-diagnosed students than in students without ADHD.
- 1 May 2008
- Published by Taylor & Francis in Journal of American College Health
- Vol. 56 (6) , 601-6
Licit and Illicit Use of Medications for Attention-Deficit Hyperactivity Disorder in Undergraduate College Students
Objective: The authors studied the relationship between a diagnosis of Attention-Deficit Hyperactivity Disorder (ADHD), grade point average (GPA), and licit and illicit drug use. Participants and Methods: They obtained survey data from a convenience sample of undergraduates in a large southern public university. Results: Among 1,550 respondents, 163 (10.5%) reported an ADHD diagnosis (ADHD Group). Of those without an ADHD diagnosis, 591 (43%) reported using prescription stimulants illicitly (No ADHD, Illicit Use group), and 794 (57%) reported not using prescription drugs illicitly (No ADHD, No Illicit Use group). The GPA of the ADHD group was significantly lower than the GPA of the other 2 groups. The ADHD group and the No ADHD, Illicit Use group reported significantly greater use of all other drugs than did the No ADHD, No Illicit Use group. Conclusions: Drug use was associated with a lower GPA in ADHD-diagnosed students than in students without ADHD.
- 1 December 2007
- Published by Springer Nature in Psychiatric Quarterly
- Vol. 79 (1) , 55-64
‘Real World’ Comparison of First- and Second-Generation Antipsychotics in Regard to Length of Inpatient Hospitalization and Number of Re-hospitalizations
The purpose of this study was to determine if Second-Generation Antipsychotics (SGAs), relative to First-Generation Antipsychotics (FGAs), reduced either the length of stay (LOS) or number of re-hospitalizations of schizophrenic patients receiving treatment in a state psychiatric hospital. Medical records were compared for the periods 1991–1994 and 2001–2004 for three inpatient groups: those receiving FGAs, those receiving SGAs, and those switched from FGAs to SGAs. During both time periods, patients on FGAs had significantly shorter LOS than either those receiving SGAs or those switched from FGAs to SGAs. Therefore, inpatients receiving SGAs were hospitalized longer than those receiving FGAs. Conversely, once discharged, patients receiving SGAs were significantly less likely to be re-admitted than patients discharged on FGAs. The data suggest that some patients do benefit from SGAs and it may be cost-effective in the long-term, to determine when to utilize FGAs first and when to switch from the older to the newer agents.
- 1 December 2007
- Published by Springer Nature in Psychiatric Quarterly
- Vol. 79 (1) , 55-64
‘Real World’ Comparison of First- and Second-Generation Antipsychotics in Regard to Length of Inpatient Hospitalization and Number of Re-hospitalizations
The purpose of this study was to determine if Second-Generation Antipsychotics (SGAs), relative to First-Generation Antipsychotics (FGAs), reduced either the length of stay (LOS) or number of re-hospitalizations of schizophrenic patients receiving treatment in a state psychiatric hospital. Medical records were compared for the periods 1991–1994 and 2001–2004 for three inpatient groups: those receiving FGAs, those receiving SGAs, and those switched from FGAs to SGAs. During both time periods, patients on FGAs had significantly shorter LOS than either those receiving SGAs or those switched from FGAs to SGAs. Therefore, inpatients receiving SGAs were hospitalized longer than those receiving FGAs. Conversely, once discharged, patients receiving SGAs were significantly less likely to be re-admitted than patients discharged on FGAs. The data suggest that some patients do benefit from SGAs and it may be cost-effective in the long-term, to determine when to utilize FGAs first and when to switch from the older to the newer agents.
- 1 July 2007
- Published by SAGE Publications in Journal of Attention Disorders
- Vol. 11 (1) , 8-16
Literature Review: Update on Amphetamine Neurotoxicity and Its Relevance to the Treatment of ADHD
Objective: A review of amphetamine treatment for attention-deficit/hyperactivity disorder (ADHD) was conducted, to obtain information on the long-term neurological consequences of this therapy. Method: Several databases were accessed for research articles on the effects of amphetamine in the brain of laboratory animals and ADHD diagnosed individuals. Results: In early studies, high doses of amphetamine, comparable to amounts used by addicts, were shown to damage dopaminergic pathways. More recent studies, using therapeutic regimens, appear contradictory. One paradigm shows significant decreases in striatal dopamine and transporter density after oral administration of “therapeutic” doses in primates. Another shows morphological evidence of “trophic” dendritic growth in the brains of adult and juvenile rats given systemic injections mimicking “therapeutic” treatment. Imaging studies of ADHD-diagnosed individuals show an increase in striatal dopamine transporter availability that may be reduced by methylphenidate treatment. Conclusion: Clarification of the neurological consequences of chronic AMPH treatment for ADHD is needed. (J. of Att. Dis. 2007; 11(1) 8-16)
- 1 July 2007
- Published by SAGE Publications in Journal of Attention Disorders
- Vol. 11 (1) , 8-16
Literature Review: Update on Amphetamine Neurotoxicity and Its Relevance to the Treatment of ADHD
Objective: A review of amphetamine treatment for attention-deficit/hyperactivity disorder (ADHD) was conducted, to obtain information on the long-term neurological consequences of this therapy. Method: Several databases were accessed for research articles on the effects of amphetamine in the brain of laboratory animals and ADHD diagnosed individuals. Results: In early studies, high doses of amphetamine, comparable to amounts used by addicts, were shown to damage dopaminergic pathways. More recent studies, using therapeutic regimens, appear contradictory. One paradigm shows significant decreases in striatal dopamine and transporter density after oral administration of “therapeutic” doses in primates. Another shows morphological evidence of “trophic” dendritic growth in the brains of adult and juvenile rats given systemic injections mimicking “therapeutic” treatment. Imaging studies of ADHD-diagnosed individuals show an increase in striatal dopamine transporter availability that may be reduced by methylphenidate treatment. Conclusion: Clarification of the neurological consequences of chronic AMPH treatment for ADHD is needed. (J. of Att. Dis. 2007; 11(1) 8-16)
- 1 February 2007
- Published by SAGE Publications in Journal of Attention Disorders
- Vol. 10 (3) , 253-256
Continuous Performance Test (CPT) of College Students With ADHD, Psychiatric Disorders, Cognitive Deficits, or No Diagnosis
Objective/Method: The Conner’s Continuous Performance Test (CPT) was administered to four groups of adult college students who self-referred for comprehensive psychoeducational evaluation and received either no diagnosis (n = 30) or a diagnosis of ADHD (n = 26), a psychiatric disorder (n = 17), or various cognitive deficits (n = 22). Results: The groups did not differ with respect to age, sex, race, or IQ. Although the ADHD group made more CPT errors of omission, had longer response times, and showed greater variability in responding than the other three groups, these differences did not reach statistical significance when analyzed parametrically using standard scores. But when the pattern of scores across the groups was analyzed nonparametrically, significant and interpretable results emerged. Conclusion: The CPT reliably differentiated between individuals with ADHD and both normal college students and individuals with psychiatric diagnoses but not persons with learning/cognitive disorders.
- 1 February 2007
- Published by SAGE Publications in Journal of Attention Disorders
- Vol. 10 (3) , 253-256
Continuous Performance Test (CPT) of College Students With ADHD, Psychiatric Disorders, Cognitive Deficits, or No Diagnosis
Objective/Method: The Conner’s Continuous Performance Test (CPT) was administered to four groups of adult college students who self-referred for comprehensive psychoeducational evaluation and received either no diagnosis (n = 30) or a diagnosis of ADHD (n = 26), a psychiatric disorder (n = 17), or various cognitive deficits (n = 22). Results: The groups did not differ with respect to age, sex, race, or IQ. Although the ADHD group made more CPT errors of omission, had longer response times, and showed greater variability in responding than the other three groups, these differences did not reach statistical significance when analyzed parametrically using standard scores. But when the pattern of scores across the groups was analyzed nonparametrically, significant and interpretable results emerged. Conclusion: The CPT reliably differentiated between individuals with ADHD and both normal college students and individuals with psychiatric diagnoses but not persons with learning/cognitive disorders.
- 1 January 2006
- Published by Taylor & Francis in Journal of Mental Health
- Vol. 15 (1) , 57-62
“Real world” study of antipsychotic effectiveness for chronic inpatients with schizophrenia in a state psychiatric hospital: Preliminary results and commentary
Background: Concerns about the therapeutic and neurological benefits of Second Generation Antipsychotics (SGAs), and financial conflicts of interest and possible biases in the recruitment of research participants, prompted this “real world” study of antipsychotic effectiveness for schizophrenia in the naturalistic setting of a public psychiatric hospital. Method: Patients who gave informed consent were evaluated with the Brief Psychiatric Rating Scale and the Clinical Global Impression Scale. Neurological side effects were rated with the Simpson-Angus Scale, the Abnormal Involuntary Movement Scale, and the Barnes Akathisia Scale. Results: During the study there were 38 eligible patients out of a total 123 admissions, but only 10 gave consent. Baseline symptoms were moderate, with minimal neurological side effects. Although 8 out of 10 received SGAs, during an average 234 days of hospitalization, there was no significant change in any measure, and little change in medications. Conclusions: These preliminary results raise questions about difficulties in patient recruitment, cost-effectiveness of SGAs, polypharmacy and criteria used to determine discharge readiness. Declaration of interest: This study was not supported by any federal, state, local or private grants.
- 1 January 2006
- Published by Taylor & Francis in Journal of Mental Health
- Vol. 15 (1) , 57-62
“Real world” study of antipsychotic effectiveness for chronic inpatients with schizophrenia in a state psychiatric hospital: Preliminary results and commentary
Background: Concerns about the therapeutic and neurological benefits of Second Generation Antipsychotics (SGAs), and financial conflicts of interest and possible biases in the recruitment of research participants, prompted this “real world” study of antipsychotic effectiveness for schizophrenia in the naturalistic setting of a public psychiatric hospital. Method: Patients who gave informed consent were evaluated with the Brief Psychiatric Rating Scale and the Clinical Global Impression Scale. Neurological side effects were rated with the Simpson-Angus Scale, the Abnormal Involuntary Movement Scale, and the Barnes Akathisia Scale. Results: During the study there were 38 eligible patients out of a total 123 admissions, but only 10 gave consent. Baseline symptoms were moderate, with minimal neurological side effects. Although 8 out of 10 received SGAs, during an average 234 days of hospitalization, there was no significant change in any measure, and little change in medications. Conclusions: These preliminary results raise questions about difficulties in patient recruitment, cost-effectiveness of SGAs, polypharmacy and criteria used to determine discharge readiness. Declaration of interest: This study was not supported by any federal, state, local or private grants.